Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …

There are currently no effective substitutes for high intensity therapy with unfractionated
heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of …

Importance Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and
serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 …

Although vaccination represents the most promising way to stop or contain the coronavirus
disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines …

Cerebral venous thrombosis (CVT) events have been reported after vaccination with
adenoviral COVID-19 vector vaccines. This study aimed to compare the clinical …

Background Diagnosing heparin-induced thrombocytopenia (HIT) at the bedside remains
challenging, exposing a significant number of patients at risk of delayed diagnosis or …

Heparin-Induced Thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its
potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis …

Background A new clinical syndrome has been recognized following the COVID-19 vaccine,
termed thrombosis with thrombocytopenia syndrome (TTS). The following systematic review …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic immune drug reaction caused
by platelet-activating antibodies that in most instances recognize platelet factor 4 …

Thrombocytopenia is a condition characterized by a decreased number of platelets in
peripheral blood, which can be caused by a myriad of both congenital and acquired …